Directional Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.07M Sell
4,903
-72
-1% -$28.7K 1.67% 17
2026
Q2
$1.8M Sell
4,975
-19
-0.4% -$6.5K 1.52% 18
2026
Q1
$1.76M Sell
4,994
-2,367
-32% -$844K 1.61% 16
2025
Q4
$2.41M Buy
+7,361
New +$2.33M 2.11% 12

Other funds holding AMGN

Directional Asset Management's AMGN Position: Q3 2026 in Review

Directional Asset Management reduced its Amgen (AMGN) stake by 1.4% in Q3 2026, selling an estimated $28.7K and leaving 4,903 shares worth $2.07M. The position accounts for 1.67% of the portfolio, ranked #17.

Directional Asset Management first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.41M in Q4 2025. 3,263 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Directional Asset Management held 4,903 shares of Amgen worth $2.07M as of Q3 2026.
  • Directional Asset Management sold 72 Amgen shares in Q3 2026, an estimated $28.7K.
  • Amgen made up 1.67% of Directional Asset Management's portfolio in Q3 2026, its #17 holding.
  • Directional Asset Management first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • Directional Asset Management's Amgen position peaked at $2.41M in Q4 2025.
  • 3,263 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Directional Asset Management's 13F filing for Q3 2026, filed 22 Oct 2026.